3804-250A

· The Dial Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 3804-250A, covering 2012-04-16 to 2012-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy Trial of 3804-250A in the Prevention of Cold Illnesses [Phase 2]